Active-ingredient Dossier

Sofosbuvir

Active-ingredient Dossier for Sofosbuvir (nucleotide polymerase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…

Brand: EPCLUSA
Brand: VOSEVI
Brand: HARVONI
Therapeutic area: Infectious Disease
Therapeutic area: Hepatology

What is

Sofosbuvir Sofosbuvir is a nucleotide polymerase inhibitor.

Australian brands containing

Sofosbuvir — VOSEVI — EPCLUSA — HARVONI

Therapeutic areas

Sofosbuvir is registered in Infectious Disease (2 brands) and Hepatology (1 brand).

Sponsor landscape

Gilead Sciences markets sofosbuvir in Australia.

PBS and regulatory activity

No sofosbuvir brands are listed on the PBS. The latest PBAC outcome was 2018-07-01 and the latest AusPAR was 2021-04-09. Three brands have PBAC outcomes on record and three brands have AusPARs on record.